We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
10 Year Est. Return
AUM
$15.6B
AUM Growth
+$469M
Cap. Flow
-$728M
Cap. Flow %
-4.67%
Top 10 Hldgs %
19.64%
Holding
1,610
New
490
Increased
294
Reduced
373
Closed
440

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$174M
2
INTC icon
Intel
INTC
+$133M
3
IMMU
Immunomedics Inc
IMMU
+$130M
4
ABBV icon
AbbVie
ABBV
+$122M
5
NEE icon
NextEra Energy
NEE
+$108M

Sector Composition

Rank Sector Weight
1 Healthcare 27.77%
2 Technology 17.59%
3 Consumer Discretionary 13.24%
4 Industrials 9.9%
5 Financials 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRNO icon
901
Terreno Realty
TRNO
$7.48B
$671K ﹤0.01%
+12,259
New +$697K
PLCE icon
902
Children's Place
PLCE
$56.3M
$666K ﹤0.01%
+23,499
New +$645K
NBIX icon
903
Neurocrine Biosciences
NBIX
$16.5B
$663K ﹤0.01%
+6,896
New +$798K
NICE icon
904
Nice
NICE
$5.99B
$661K ﹤0.01%
+2,914
New +$620K
DDOG icon
905
Datadog
DDOG
$90.3B
$660K ﹤0.01%
6,465
-4,159
-39% -$362K
NYT icon
906
New York Times
NYT
$10.3B
$657K ﹤0.01%
15,358
-26,509
-63% -$1.16M
IIIV icon
907
i3 Verticals
IIIV
$329M
$655K ﹤0.01%
+25,943
New +$695K
SNAP icon
908
Snap
SNAP
$9.23B
$652K ﹤0.01%
+24,990
New +$581K
VC icon
909
Visteon
VC
$2.84B
$646K ﹤0.01%
9,330
-150
-2% -$11.1K
XLNX
910
DELISTED
Xilinx Inc
XLNX
$642K ﹤0.01%
6,162
+1,900
+45% +$195K
NARI
911
DELISTED
Inari Medical, Inc. Common Stock
NARI
$639K ﹤0.01%
9,255
-17,664
-66% -$1.14M
BIP icon
912
Brookfield Infrastructure Partners
BIP
$18.2B
$638K ﹤0.01%
20,108
-61,651
-75% -$1.81M
NXTC icon
913
NextCure
NXTC
$30.9M
$634K ﹤0.01%
6,015
+261
+5% +$32.1K
SIRI icon
914
SiriusXM
SIRI
$9.66B
$630K ﹤0.01%
11,751
+6,057
+106% +$347K
CENT icon
915
Central Garden & Pet Co
CENT
$2.72B
$629K ﹤0.01%
+19,676
New +$616K
PKG icon
916
Packaging Corp of America
PKG
$22.9B
$629K ﹤0.01%
5,770
-22,152
-79% -$2.26M
DGX icon
917
Quest Diagnostics
DGX
$26.3B
$627K ﹤0.01%
5,480
-478,514
-99% -$56.5M
VSAT icon
918
Viasat
VSAT
$11.7B
$625K ﹤0.01%
+18,153
New +$687K
LFUS icon
919
Littelfuse
LFUS
$11.6B
$622K ﹤0.01%
+3,509
New +$623K
EPRT icon
920
Essential Properties Realty Trust
EPRT
$6.55B
$620K ﹤0.01%
33,811
-40,355
-54% -$684K
PBI icon
921
Pitney Bowes
PBI
$2.28B
$620K ﹤0.01%
+116,648
New +$538K
CMPR icon
922
Cimpress
CMPR
$2.35B
$605K ﹤0.01%
+8,043
New +$689K
TECK icon
923
Teck Resources
TECK
$32.5B
$605K ﹤0.01%
43,600
-34,885
-44% -$413K
MAN icon
924
ManpowerGroup
MAN
$2.59B
$603K ﹤0.01%
8,216
-18,452
-69% -$1.33M
HES
925
DELISTED
Hess
HES
$601K ﹤0.01%
+14,685
New +$698K

Similar funds

Marshall Wace North America's Q3 2020 Portfolio in Review

As of Q3 2020, Marshall Wace North America held 1,610 positions worth $15.6B, up 3.1% from $15.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Marshall Wace North America withdrew a net $728M in Q3 2020, closing 440 positions and reducing 373 holdings. Its most notable exit was Intel, an estimated $133M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in Keurig Dr Pepper worth $49.9M.

  • Marshall Wace North America's largest Q3 2020 buy was Keurig Dr Pepper: 1,808,999 shares worth $49.9M.
  • Marshall Wace North America added most to Danaher in Q3 2020, an estimated $141M increase.
  • Marshall Wace North America's biggest Q3 2020 reduction was UnitedHealth, cutting an estimated $174M.
  • Marshall Wace North America fully exited Intel in Q3 2020, selling an estimated $133M.
  • Marshall Wace North America's ten largest holdings make up 20% of its $15.6B portfolio in Q3 2020.
  • Marshall Wace North America opened 490 new positions and closed 440 in Q3 2020.
  • Marshall Wace North America's portfolio value rose 3.1% quarter-over-quarter to $15.6B.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.